Impact 2020 Twitter Chat: Crossroads – The Intersection of Biotech, Tech, and Devices & Diagnostics in Massachusetts: Opportunity Untapped?

Tuesday, February 18 2014
8:00 pm – 9:00 pm

Location: #Impact2020 & @MassBio on Twitter or TweetChat

MassBio continues its #Impact2020 Twitter Chats with a topic that taps a unique potential we have in Massachusetts. With such strong life sciences AND tech industries in the region, we’ll discuss the opportunity that may lie at the intersection of the two.

Join MassBio CEO @BobCoughlin and @MassTLC CEO Tom Hopcroft as we explore how and where these industries intersect in a Twitter Chat scheduled for Tuesday, February 18th at 8 p.m. ET.

We’ll talk about whether we’re doing all we should to leverage the density of the leading industries or whether we’re leaving opportunities on the table. We’ll explore questions such as:

  • Should life sciences and technology seek to collaborate more than they do now?
  • Is the combination of devices, IT, diagnostics, and biotech potent enough to catalyze unique collaborations and spawn new industry models?
  • What can Big Data do for life sciences and vice versa?
  • Who will spearhead these partnerships and why doesn’t more seem to be happening?

Join our guest moderator, Tom Hopcroft, President and CEO of Massachusetts Technology Leadership Council (@MassTLC) and MassBio CEO Bob Coughlin (@BobCoughlin), in a conversation that is sure to bring together an interesting mix of experts and observers across both sectors.

You can participate using #Impact2020 and follow the conversation here online.

We look forward to chatting with you Tuesday from 8-9 p.m.

 

About Tom Hopcroft

Tom Hopcroft is President & CEO of the Mass Technology Leadership Council, Inc., an organization dedicated to fostering entrepreneurship and promoting the success of companies that develop and deploy technology across a variety of industry sectors. A Massachusetts attorney, Mr. Hopcroft formerly led and founded the New England Business and Technology Association (NEBATA), which merged with the Mass Software Council in 2005. Since the merger, he led cluster activities for the organization, growing the cluster portfolio from three to ten active groups.

Share MassBio

 

BioProcess

EvaluatePharma 

MassBio